Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis

Background. Rasagiline is a selective, irreversible monoamine oxidase type B inhibitor used as monotherapy in early Parkinson’s disease and as an adjunct therapy to levodopa in Parkinson’s disease with motor fluctuations. Objectives. This meta-analysis aimed to provide updated evidence on the effica...

Full description

Saved in:
Bibliographic Details
Main Authors: Osamu Kano, Hiroshi Tsuda, Ayako Hayashi, Masaki Arai
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2022/4216452
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items